243
Views
4
CrossRef citations to date
0
Altmetric
Articles

The potential hazardous effect of exposure to iron dust in Egyptian smoking and nonsmoking welders

, , &
Pages 189-202 | Received 29 Jul 2016, Accepted 28 Mar 2017, Published online: 01 May 2017

References

  • Corhay JL, Weber G, Bury T. Iron content in human alveolar macrophages. Eur Respir J. 1992;5:804–809.
  • Wesselius LJ, Flowers CH, Skikne BS. Alveolar macrophage content of isoferritins and transferrin. Comparison of nonsmokers and smokers with and without chronic airflow obstruction. Am Rev Respir Dis. 1992;145:311–316.
  • Thompson AB, Bohling T, Heires A. Lower respiratory tract iron burden is increased in association with cigarette smoking. J Lab Clin Med. 1991;117:493–499.
  • Nelson ME, O'Brien-Ladner AR, Wesselius LJ. Regional variation in iron and iron-binding proteins within the lung of smokers. Am J Respir Crit Care Med. 1996;153:1353–1358.
  • Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health. Criteria for a recommended standard: welding, brazing and thermal cutting. Atlanta, GA: DHHS (NIOSH); 1988. Publication No. 88–110.
  • Sørensen AR, Thulstrup AM, Hansen J, et al. Risk of lung cancer according to mild steel and stainless steel welding. Scand J Work Environ Health. 2007;33:379–386.
  • Ambroise D, Wild P, Moulin JJ. Update of a meta-analysis on lung cancer and welding. Scand J Work Environ Health. 2006;32:22–31.
  • Moulin JJ. A meta-analysis of epidemiologic studies of lung cancer in welders. Scand J Work Environ Health. 1997;23:104–13.
  • Sjögren B, Hansen KS, Kjuus H, Persson PG. Exposure to stainless steel welding fumes and lung cancer: a meta-analysis. Occup Environ Med. 1994;51:335–336.
  • Steenland K, Beaumont J, Elliot L. Lung cancer in mild steel welders. Am J Epidemiol. 1991;133:220–229.
  • Antonini JM, Taylor MD, Zimmer AT, Roberts JR. Pulmonary responses to welding fumes: role of metal constituents. J Toxicol Environ Health A. 2004;67:233–249.
  • Steenland K, Beaumont J, Hornung R. The use of regression analyses in a cohort mortality study of welders. J Chronic Dis. 1986;39:287–294.
  • Stokinger HE. A review of world literature finds iron oxides noncarcinogenic. Am Ind Hyg Assoc J. 1984;45:127–133.
  • Meo SA, Azeem MA, Subhan MM. Lung function in Pakistani welding workers. J Occup Environ Med. 2003;45:1068–1073.
  • Toren K, Jarvholm B, Brisman J, Hagberg S, Hermansson BA, Lillienberg L. Adult-onset asthma and occupational exposures. Scand J Work Environ Health. 1999;25:430–435.
  • Antonini JM, Afshari AA, Stone S, et al. 2006. Design, construction, and characterization of a novel robotic welding fume generator and inhalation exposure system for laboratory animals. J Occup Environ Hyg. 2006;3:194–203.
  • Shulka A, Timblin C, BeruBe K, et al. Inhaled particulate matter causes expression of nuclear factor (NF)-kB–related genes and oxidant-dependent NF-kB activation in vitro. Am J Respir Cell Mol Biol. 2000;23:182–187.
  • Kang JL, Pack IS, Hong SM, Lee HS, Castranova V. Silica induces nuclear factor-B activation through tyrosine phosphorylation of IkB in RAW264.7 macrophages. Toxicol Appl Pharmacol. 2000;169:59–65.
  • Ghio AJ, Richards JH, Carter JD, Madden MC. Accumulation of iron in the rat lung after tracheal instillation of diesel particles. Toxicol Pathol. 2001;28:619–627.
  • Yende S, Angus DC, Ali IS. Influence of comorbid conditions on long-term mortality after pneumonia in older people. J Am Geriatr Soc. 2007;55:518–525.
  • Almirall J, Bolibar I, Serra-Prat M. New evidence of risk factors for community-acquired pneumonia: a population-based study. Eur Respir J. 2008;31:1274–1284.
  • Mullerova H, Chigbo C, Hagan GW. The natural history of community-acquired pneumonia in COPD patients: a population database analysis. Respir Med. 2012;106:1124–1133.
  • Dye JA, Adler KB. Effects of cigarette smoke on epithelial cells of the respiratory tract. Thorax. 1994;49:825–834.
  • Simeonova PP, Luster MI. Iron and reactive oxygen species in the asbestos-induced tumor necrosis factor-α response from alveolar macrophages. Am J Respir Cell Mol Biol. 1995;12:676–683.
  • Ghio AJ, Kennedy TP, Whorton ARD, Crumbliss AL, Hatch GE, Hoidal JR. Role of surface complexed iron in oxidant generation and lung inflammation induced by silicates. Am J Physiol. 1992;263:L511–L518.
  • Luo JC, Hsu KH, Shen WS. Pulmonary function abnormalities and airway irritation symptoms of metal fumes exposure on automobile spot welders. Am J Ind Med. 2006;49:407–416.
  • Bheekie A, Syce JA, Weinberg EG. Peak expiratory flow rate and symptom self-monitoring of asthma initiated from community pharmacies. J Clin Pharm Ther. 2001;26:287–296.
  • Corti A, Fassina G, Marcucci F, Barbanti E, Cassani G. Oligomeric tumour necrosis factor alpha slowly converts into inactive forms at bioactive levels. Biochem J. 1992;284:905–910.
  • Malek TR. The biology of interleukin-2. Annual Rev Immunol. 2008;26:453.
  • Mingam R, Moranis A, Bluthé RM, De Smedt-Peyrusse V, Kelley KW. Uncoupling of interleukin-6 from its signalling pathway by dietary n-3-polyunsaturated fatty acid deprivation alters sickness behaviour in mice. Eur J Neurosci. 2008;28:1877–1886.
  • Chi W, Zhu X, Yang P, Liu X, Lin X. Upregulated IL-23 and IL-17 in Behçet patients with active uveitis. Invest Ophthalmol Vis Sci. 2008;49:3058–3064.
  • Vaishnavi C. Immunol Infect Dis. 1996;6:144.
  • Makimura S, Suzuki N. Quantitative determination of bovine serum haptoglobin and its elevation in some inflammatory diseases. Jpn J Veterinary Sci. 1982;44:15–21.
  • Grunbaum AM, Mattman A, Gilfix BM. Performance studies on a nephelometric assay for alpha1-antitrypsin. J Biochem. 2011;44:1171.
  • Ridascreen Histamine [package insert]. Darmstadt, Germany: R- Biopharm AG; 2004.
  • Plebani M, Bernardi D, Basso D, Faggian D, Borghesan F. Measurement of specific immunoglobulin E. Method comparison and standardization. J Clin Chem. 1998;44:1974–1979.
  • Chan DW, Perlstein NT. Immunoassay: A Practical Guide. New York, NY: Academic Press; 1987.
  • Grani G, Nesca A, Del Sordo M, et al. Interpretation of serum calcitonin in patients with chronic autoimmune thyroiditis. Endocrine-Related Cancer. 2012;19:345–349.
  • Roberts WL, Moulton L, Law TC, et al. Evaluation of nine automated high sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2. Clin Chem. 2001;47:418–425.
  • Roman W, Rays J. Colourimetric estimation of arginase in serum. Congress Clin Chem. 1970;2:121.
  • Zietke K, Okada S, O'Brien JS. Fucosidosis diagnosis by serum assay a-L-fucosidase. J Lab Clin Med. 1972;79:1649–1654.
  • Bauer JD, ed. Clinical Laboratory Methods (9th ed). Maryland Heights, MO: Mosby; 1982.
  • Esterbauer H, Schaure R, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal malonaldehyde and related aldehydes. Free Radic Biol Med. 1991;11:81–128.
  • Suttle N. Copper deficiency in ruminants; recent developments. Vet Rec. 1986;119:519–522.
  • Paglia D, Valentine W. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70:158–169.
  • Horn D. Glutathione reductase. In: Bergmayer H, ed. Methods in Enzymatic Analysis. New York, NY: Academic Press; 1965:406–433.
  • Sinha AK. Colorimetric assay of catalase. Ann Biochem. 1972;47:389–394.
  • SPSS. SPSS 15. Chicago, IL: SPSS Inc.; 2012.
  • Samet J.M, Dominici F, Curriero FC, Coursac I, Zeger SL. Fine particulate air pollution and mortality in 20 US cities 1987–1994. N Engl J Med. 2000; 343:1742–1749.
  • Abbey DE, Burchette RJ, Knutsen SF, McDonnell WF, Lebowitz MD, Enright PL. Long-term particulate and other air pollutants and lung function in nonsmokers. Am J Respir Crit Care Med. 1998;158:289–298.
  • Abbey DE, Nishino N, McDonnell WF, et al. Long-term inhalable particles and other air pollutants related to mortality in nonsmokers. Am J Respir Crit Care Med. 1999;159:373–382.
  • Sunyer J. Urban air pollution and chronic obstructive pulmonary disease: a review. Eur Respir J. 2001;17:1024–1033.
  • Bradshaw LM, Fishwick D, Slater T, Pearce N. Chronic bronchitis, work related respiratory symptoms and pulmonary function in welders in New Zealand. Occup Environ Med. 1998;55:150–154.
  • Pouryaghoub G, Mortazavi AS, Mehrdad R. Peak Expiratory flow changes among welders. Int J Occup Hyg. 2015;7:83–88.
  • Donoghue AM, Glass WI, Herbison GP. Transient changes in the pulmonary function of welders: a cross sectional study of Monday peak expiratory flow. Occup Environ Med. 1994;51:553–556.
  • Guojun J, Long-Lian Z, Ling L, Ping W, Wei Z. Occupational exposure to welding fume among welders: alterations of manganese, iron, zinc, copper, and lead in body fluids and the oxidative stress status. JOEM. 2004;3:241–249.
  • McGowan SE, Henley SA. Iron and ferritin contents and distribution in human alveolar macrophages. J Lab Clin Med. 1988;111:611–617.
  • Stites SW, Nelson ME, Wesselius LJ. Transferrin concentrations in serum and lower respiratory tract fluid of mechanically ventilated patients with COPD or ARDS. Chest. 1995;107:1681–1685.
  • Bell DY, Haseman JA, Spock A, et al. Plasma proteins of the bronchoalveolar surface of the lungs of smokers and non-smokers. Am Rev Respir Dis. 1981;124:72–79.
  • Britton RS, Tavill AS, Bacon BR. Mechanisms of iron toxicity. In: Brock JH, Halliday JW, Pippard MJ, Powell LW, eds. Iron Metabolism in Health and Disease. London, UK: WB Saunders; 1994:311–351.
  • Gutteridge JM, Mumby S, Quinlan GJ, et al. Pro-oxidant iron is present in human pulmonary epithelial lining fluid: implications for oxidative stress in the lung. Biochem Biophys Res Commun. 1996;220:1024–1027.
  • Lenz AG, Costabel U, Maier KL. Oxidized BAL fluid proteins in patients with interstitial lung diseases. Eur Respir J. 1996;9:307–312.
  • Kime R, Gibson A, Yong W, et al. Chromatographic method for the determination of non-transferrin-bound iron suitable for use and bronchoalveolar lavage fluid of preterm babies. Clin Sci. 1996;91:633–638.
  • Clarkson AB, Saric M, Grady RW. Deferoxamine and eflornithine (DL-á-difluoro methyl ornithine) in a rat model of Pneumocystis carinii pneumonia. Antimicrob Agents Chemother. 1990;34:1833–1835.
  • LaLonde C, Ikegami K, Demling R. Aerosolized deferoxamine prevents lung and systemic injury caused by smoke inhalation. J Appl Physiol. 1994;77:2057–2064.
  • Freeman BA, Crapo JD. Free radicals and tissue injury. Lab Invest. 1982;47:412–416.
  • Cross CE, Halliwell B, Borisch ET. Oxygen radicals and human disease. Ann Intern Med. 1987;107:526–545.
  • Fernando M, Jeremy H, José Luis P. Iron metabolism in the lower respirator y tract. Thorax. 1998;53:594–600.
  • Ghio AJ, Richards J, Carter JD, Madden MC. Accumulation of iron in the rat lung after tracheal instillation of diesel particles. Toxicol Pathol. 2004;28:619–627.
  • Shulka A, Timblin C, BeruBe K, et al. Inhaled particulate matter causes expression of nuclear factor (NF)-B–related genes and oxidant-dependent NF-B activation in vitro. Am J Respir Cell Mol Biol. 2000;23:182–187.
  • Jimenez LA, Thompson J, Brown DA, et al. Activation of NF-B by PM10 occurs via an iron-mediated mechanism in the absence of IB degradation. Toxicol Appl Pharm. 2000;166:101–110.
  • Schwiebert A, Lisa AB, Cristiana S, Carol AB, Bruce SB, Robert PS. Glucocorticosteroid inhibition of cytokine production: relevance to anti-allergic actions. J Allergy Clin Immunol. 1996;97,143–125.
  • Valko M, Morris H, Cronin MT. Metal, toxicity and oxidative stress. Curr Med Chem. 2005;12:1161–1208.
  • Sayre LM, Moreira PI, Smith MA, Perry G. Metal ions and oxidative protein modification in neurological disease. Ann Ist Super Sanita. 2005;41:143–164.
  • Gushchin I, Petyaev I, Tsinkalovsky O. Kinetics of oxygen metabolism indices in the course of histamine secretion from rat mast cells. Agents Actions. 1990;30:85–88.
  • Wolfreys K, Oliviera D. Alterations in intracellular reactive oxygen species generation and redox potential modulate mast cell function. Eur J Immunol. 1997;27:297–306.
  • Mannaioni PF, Masini E, Pistelli A, Salvemini D, Vane J. Mast cells as a source of superoxide anions and nitric oxide like factor: relevance to histamine release. Int J Tissue React. 1991;XIII:271–278.
  • Salvemini D, Masini E, Pistelli A, Mannaioni PF, Vane J. Nitric oxide: a regulatory mediator of mast cell reactivity. J Cardiovasc Pharmacol. 1991;17:S258–S264.
  • Luna CM. C-Reactive protein in pneumonia. Chest. 2004;125:1192–1195.
  • Grani G, Nesca A, Del Sordo M, et al. Interpretation of serum calcitonin in patients with chronic autoimmune thyroiditis. Endocrine-Related Cancer. 2012;19:345–349.
  • Stoller JK, Tomashefski J Jr, Crystal RG, Arroliga A, Strange C, Killian DN. Mortality in individuals with severe deficiency of alpha1-antitrypsin: findings from the National Heart, Lung, and Blood Institute registry. Chest. 2005;127:1196–204.
  • Mordwinkin NM, Louie SG. Aralast: an alpha 1-protease inhibitor for the treatment of alpha-antitrypsin deficiency. Chest. 2007; 8:2609–2614.
  • Salovsky P, Shopova V, Dancheva V. Pneumotoxic effects of radioactive dust (RD) from a nuclear power plant in Kozloduy, Bulgaria. Am J Ind Med. 2000;38:639–643.
  • Salovsky P, Shopova V, Dancheva V. Antioxidant defense mechanisms in the lung toxicity of tri-n-butyl phosphate. Am J Ind Med. 1998;33:11–15.
  • Merrick B, Bruno E, Madwnspacher B, et al. Alterations in the rat serum proteom during liver injury from acetaminophen. J Pharmacol Exp Ther. 2006;318:792–802.
  • Ceribas AO, Turk G, Sonmez M, Sakin F, Ates A. Toxic effect of cyclophosphamide on sperm morphology, testicular histology and blood oxidant–antioxidant balance, and protective roles of lycopene and ellagic acid. Basic Clin Pharmacol Toxicol. 2010;107:730–736.
  • Satriano J. At the crossroads of the arginine pathways. Ann NY Acad Sci. 2003;1009:34–43.
  • Othman AM, El-Houseini ME, ElSofy MS, Aboul-Enein HY. Potent iometric determination of α-L-fucosidase enzyme by using 2-chloro-4- nitrophenol-rhodamine B ion pair chemical recognition in PVC membrane sensor. Anal Bioanal Chem. 2011;400:787–795.
  • Sivaramakrishnan V, Shilpa P, Praveen V, Niranjali D. Attenuation of Nnitrosodiethylamine induced hepatocellular carcinogenesis by a novel flavonol-Morin. Chem Biol Interactions. 2007;171:79–88.
  • Butterfield DA, Kanski J. Brain protein oxidation in age related neuro degenerative disorders that are associated with aggregated proteins. Mech Ageing Dev. 2001;122:945–962.
  • Chen L, Zhang BH. Evidence suggesting that nitric oxide mediates iron-induced toxicity in cultured proximal tubule cells. Am J Physiol Ren. 1998;274;18–25.
  • Chen L, Wang Y. Molecular mechanisms by which iron induces nitric oxide synthesis in cultured proximal tubule cells. Exp Nephrol. 2001;9:198–204.
  • Toyokuni S. Iron and carcinogenesis: from Fenton reaction to target gene. Redox Rep. 2002;7:189–197.
  • Veerappan RM, Senthil S, Rao MR, Ravikumar R. Redox status and lipid peroxidation in alcoholic hypertensive patients and alcoholic hypertensive patients with diabetes. Clin Chem Acta. 2004;340:207–212.
  • Kannampalli P, Sang HP, Kyong CK. Hesperidin a flavanoglycone protects against irradiation-induced hepatocellular damage and oxidative stress in Sprague Dawley rats. Eur J Pharmacol. 2008;587:273–280.
  • Mccord JM, Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem. 1964;244:6049–6055.
  • Deisseroth A, Dounce DL. Catalase: physical and chemical properties, mechanism of catalysis. Physiol Role Physiol Rev. 1970;50:319–375.
  • Deneke SM, Fanburg BL. Regulation of cellular glutathione. Am J Physiol Lung Cell Mol Physiol. 1989;257:163–173.
  • Eaton JW. Catalase, glutathione peroxidase and hydrogen peroxidase. J Clin Lab Med. 1991;118:3–4.
  • Abd El-Maksouda HA, Salemb L, El-Harrif MG. Biochemical alterations on occupational stress between smoking and non-smoking iron & steel workers in Egypt. J Toxicol Health. 2013;103:202–210.
  • Rahman I, Morrison D, Donaldson K. Systemic oxidative stress in asthma, COPD and smokers. Am J Respir Crit Care Med. 1996;154:1055–1060.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.